BARCLAYS PLC

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 312069 LONDON, X0

Position in TSHA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$12,569,684

-$17,894,821 QoQ

Shares Held

2,812,010

-49.2% QoQ

Ownership

0.979%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2022

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

BARCLAYS PLC holds $1,494,072,071 across 362 Biotechnology names. TSHA ranks #23 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	663,263	$296,173,457
2	REGN	Regeneron Pharmaceuticals, Inc.	313,093	$241,908,173
3	ALNY	Alnylam Pharmaceuticals, Inc.	220,623	$72,997,531
4	MRNA	Moderna, Inc.	932,269	$47,359,264
5	INSM	INSMED Inc	275,731	$45,087,531
6	ROIV	Roivant Sciences Ltd.	1,415,848	$39,218,988
7	RVMD	Revolution Medicines, Inc.	383,179	$37,264,156
8	TERN	Terns Pharmaceuticals, Inc.	669,601	$35,301,364

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$12,569,684	2,812,010	-49.2%	Shares	Defined	2026-05-15
2025-12-31	$30,464,505	5,539,001	+7.6%	Shares	Sole	2026-02-13
2025-09-30	$16,834,326	5,148,112	+1042.8%	Shares	Sole	2026-03-31
2025-06-30	$1,040,657	450,501	-36.5%	Shares	Sole	2026-02-27
2025-03-31	$985,462	708,966	+111.5%	Shares	Sole	2026-03-17
2024-12-31	$579,961	335,238	+35.6%	Shares	Sole	2026-03-19
2024-09-30	$497,032	247,280	+356.0%	Shares	Sole	2026-03-31
2024-06-30	$121,484	54,234	+23.2%	Shares	Sole	2026-03-23
2022-12-31	$99,469	44,013	-8.1%	Shares	Sole	2026-03-30
2022-09-30	$92,406	47,879	0.0%	Shares	Sole	2022-11-03
2022-06-30	$178,109	47,879	+7.9%	Shares	Sole	2022-08-12
2022-03-31	$289,403	44,387	—	Shares	Sole	2022-05-16
No filing history on record for this holder in this stock.